logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

Spain, a pioneer country against counterfeiting drugs

June 8, the World Day against Counterfeiting and Piracy is celebrated
Our country was one of the first and with the highest volume of activity to connect with the European hub for the verification of medicines, in application of the directive of the European Union

More than 1,450 million drug presentations already have a unique identifier that prevents counterfeit drugs from entering the official supply chain

Source: www.farmaindustria.es

Like every June 8, today is the World Day against Counterfeiting and Piracy, an aspect in which Spain is at the forefront of Europe in the field of medicines. The Spanish Drug Verification System (SEVeM) was one of the national entities that, with the greatest speed and volume of activity, connected, in February 2019, to the European hub against counterfeiting, which made our country one of the first in adopting the new European directive. Since then, thanks to this collaborative project of the entire pharmaceutical sector – manufacturing laboratories, distributors and pharmacies – in Spain, it is possible to differentiate one medicine container from another by means of a unique identifier, making it virtually impossible for counterfeit drugs to enter the chain. legal supply.

Thanks to the platform, launched by Farmaindustria, the Spanish Association of Generic Medicines (Aeseg), the Federation of Pharmaceutical Distributors (Fedifar) and the General Council of Pharmaceutical Colleges, currently more than 1,450 million drug presentations already have a unique identifier, which has allowed more than 285 million containers to be verified by this system at this time (with an average activity of 2 million verified containers per day). 465 drug marketing authorization holders (TACs), 302 distribution warehouses, almost all pharmacies (22,100) and 178 hospitals have already connected to the Spanish platform.

A two-device system

The anti-counterfeiting drug system affects prescription drugs that have to be provided with two security devices since then. The pharmaceutical manufacturing companies in Spain had to adapt all their production lines to be able to include these devices in all drug boxes, which represented an investment of approximately 200 million euros.

The first device is a unique identifier (in the form of a datamatrix code) that contains the product code, a 20-character serial number generated by a scrambling algorithm, the batch number, and the expiration date. In this way, the authenticity is verified and each medication container is individually identified through a telematic connection between the pharmacy and the repository of authentic codes at the time of dispensing. Additionally, in the case of Spain, and at the request of the national authorities, the datamatrix code also contains the national refund number, either within the product code itself or in another field.

The second security device is an anti-tamper system to guarantee that the container has not been opened from its exit from the production chain until its dispensation in the pharmacy office.

In the first year of SEVeM’s operation – which took place on February 9 – more than 770 million operations had been carried out in Spain, with a success rate of 98%. Due to the size of the project, there is a period of stabilization of the system until it reaches 100% operation. In addition, it must be borne in mind that the maximum expiration date of the medicines is established in five years, for which reason all the products put on the market before February 9 of last year have not yet been released and do not have the safety devices of the new procedure.

Last week was the World Day Against Counterfeiting and Piracy. Spain is positioned as a pioneer country against counterfeiting drugs.

Related entries

2 October, 2023

Decentralisation of trials, networking and digitisation, proposals to improve patient participation in clinical research


Leer más
26 September, 2023

More than 120 molecules in Alzheimer’s research, the great hope for patients, families and society


Leer más
19 September, 2023

The pharmaceutical industry’s plan to expand clinical trials in primary care


Leer más

Recent Posts

  • Decentralisation of trials, networking and digitisation, proposals to improve patient participation in clinical research
  • More than 120 molecules in Alzheimer’s research, the great hope for patients, families and society
  • The pharmaceutical industry’s plan to expand clinical trials in primary care
  • Health commitment to the pharmaceutical industry’s Strategic Plan to avoid losing 8,000 million euros
  • Improving patient access to innovative medicines and boosting R&D and manufacturing in Spain are the main priorities of the pharmaceutical industry

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

DELEGACIÓN MADRID

+34 674 575 115
28010 Madrid

Enlaces de interés

  • Aviso Legal
  • Política de privacidad
  • Política de cookies
  • Contacto

© 2023 Distefar del Sur SL. Todos los derechos reservados. agencianodo.com

  • Contact
  • Private Zone
  • Español
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.